- Home
- NVT vs ICLR Comparison
NVT vs ICLR Comparison
Compare NVT & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVT | ICLR |
|---|---|---|
| Founded | 1903 | 1990 |
| Country | United Kingdom | Ireland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8B | 15.1B |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | NVT | ICLR |
|---|---|---|
| Price | $105.45 | $181.56 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 14 |
| Target Price | $107.58 | ★ $201.46 |
| AVG Volume (30 Days) | ★ 2.2M | 889.8K |
| Earning Date | 02-05-2026 | 02-18-2026 |
| Dividend Yield | ★ 0.82% | N/A |
| EPS Growth | ★ 6.36 | N/A |
| EPS | 3.64 | ★ 7.47 |
| Revenue | $3,578,600,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $28.70 | N/A |
| Revenue Next Year | $14.97 | $0.66 |
| P/E Ratio | $28.24 | ★ $25.18 |
| Revenue Growth | ★ 21.54 | N/A |
| 52 Week Low | $41.71 | $125.10 |
| 52 Week High | $117.52 | $221.80 |
Technical Indicators
Market Signals| Indicator | NVT | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 51.53 | 48.48 |
| Support Level | $102.00 | $171.99 |
| Resistance Level | $110.65 | $203.91 |
| Average True Range (ATR) | 2.99 | 6.70 |
| MACD | 0.29 | 0.22 |
| Stochastic Oscillator | 56.14 | 34.77 |
Price Performance
Historical ComparisonAbout NVT nVent Electric plc
NVent is a leading global provider of electrical connection and protection solutions that touch a broad range of end markets, including infrastructure, industrial, commercial, and residential. NVent designs, manufactures, markets, installs, and services a portfolio of electrical enclosures and electrical fastening solutions. North America accounts for the majority of sales.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.